Skip to main content
OpenTrials
Completed

NCT Number: NCT04477031

Verification of the Safety of Normal Food Before a Cerebral Arteriography

Fasting is currently required before elective cerebral angiography, despite numerous arguments against fasting (kidney toxicity, vasovagal reaction, discomfort) and seams unusefull regarding it's main goal : reducing nausea and vomiting. The investigators propose to assess frequency of nausea and vomiting among patients having taken their breakfast at home before day care angiography.

The investigators hypothesise that less than 1% of non fasting patients will suffer of vomitint.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cerebral Angiography Behavior Fasting Feeding Behavior Nausea Pathological Conditions, Signs and Symptoms Signs and Symptoms Signs and Symptoms, Digestive Vomiting

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU de Nantes

Nantes, 44093, France

About this study

Fasting is currently required before elective cerebral angiography, despite numerous arguments against fasting (kidney toxicity, vasovagal reaction, discomfort) and seams unusefull regarding it's main goal : reducing nausea and vomiting. The investigators propose to assess frequency of nausea and vomiting among patients having taken their breakfast at home before day care angiography.

The investigators hypothesise that less than 1% of non fasting patients will suffer of vomitint.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult,
  • non fasting,
  • day care hosptilalisation

Exclusion criteria

  • Childs,
  • pregnancy,
  • parenteral nutrition,
  • nausea,
  • vomiting before arteriography,
  • arteriography under general anesthesia

Treatment and study plan

Primary outcomes

  1. frequency of vomiting during arteriographic procedure

    Time frame: fifteen minutes

    The investigators check if there is vomiting or not during the examination noted by an electro radiology manipulator. Safety issue : Bronchus inhalation

Secondary outcomes

  1. nausea

    Time frame: fifteen minutes

    The nausea will be evaluated using an analog visual scale (EVA) by an electro-radiology manipulator (MAR)at the exit of the intervention room

Sponsors and collaborators

Lead sponsor

Nantes University Hospital

Other

Registry information

Acronym: VIANAC

Important dates

Study start
2020
Primary completion
2024
Study completion
2024
First posted
Jul 20, 2020
Registry last updated
Jul 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.